Medicare Enrolled
Dr. Deepak Amin, MD
Internal Medicine · Union City, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Amin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Amin
Dr. Deepak Amin is an internal medicine specialist in Union City, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Amin performed 6,304 Medicare services across 1,806 unique beneficiaries.
Between the years covered by Open Payments, Dr. Amin received a total of $31,374 from 60 pharmaceutical and/or device companies across 717 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Amin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in NJ
$31,374 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,304
Medicare services
Top 4% in NJ for internal medicine
1,806
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~315 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,133 | $103 | $307 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
1,014 | $64 | $182 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
727 | $103 | $316 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
471 | $35 | $110 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
448 | $91 | $255 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
423 | $69 | $215 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
372 | $12 | $90 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
299 | $1 | $25 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
269 | $148 | $586 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
242 | $75 | $125 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
184 | $74 | $208 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
122 | $84 | $100 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
112 | $34 | $50 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
100 | $0 | $46 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
98 | $144 | $299 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
96 | $76 | $100 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
42 | $244 | $500 |
| Lincomycin antibiotic injection An injection of lincomycin hydrochloride, an antibiotic medication, administered in a dose of up to 300 mg. |
35 | $8 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $119 | $469 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
21 | $33 | $50 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
18 | $183 | $300 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
14 | $4 | $34 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
13 | $184 | $300 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
12 | $116 | $278 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
11 | $13 | $93 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$31,374
Total received (2018-2024)
Avg $4,482/year across 7 years
Top 2% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
717
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,774 (82.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,600 (17.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,104
2023
$5,562
2022
$3,660
2021
$4,806
2020
$2,280
2019
$3,300
2018
$6,662
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$949
Boehringer Ingelheim Pharmaceuticals, Inc.
$647
GlaxoSmithKline, LLC.
$578
Intra-Sana Laboratories
$538
Amgen Inc.
$420
Exact Sciences Corporation
$323
ABBVIE INC.
$265
Novo Nordisk Inc
$247
Janssen Pharmaceuticals, Inc
$232
Merck Sharp & Dohme LLC
$164
PFIZER INC.
$153
Lilly USA, LLC
$145
Phathom Pharmaceuticals, Inc.
$135
Inari Medical, Inc.
$132
Novartis Pharmaceuticals Corporation
$72
Astellas Pharma US Inc
$31
IRONWOOD PHARMACEUTICALS, INC
$30
Kowa Pharmaceuticals America, Inc.
$28
Azurity Pharmaceuticals, Inc.
$16
Top 3 companies account for 42.6% of 2024 payments
All-time payments by company (2018-2024) ›
Synergy Pharmaceuticals Inc
$5,600
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,114
GlaxoSmithKline, LLC.
$3,723
Amgen Inc.
$2,934
AstraZeneca Pharmaceuticals LP
$2,781
Novo Nordisk Inc
$2,127
Lilly USA, LLC
$980
Janssen Pharmaceuticals, Inc
$942
Medtronic Vascular, Inc.
$610
Allergan Inc.
$585
Intra-Sana Laboratories
$538
Exact Sciences Corporation
$482
ABBVIE INC.
$418
AbbVie Inc.
$389
ABIOMED
$373
PFIZER INC.
$363
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$326
Ironwood Pharmaceuticals, Inc
$315
Bayer HealthCare Pharmaceuticals Inc.
$300
Amarin Pharma Inc.
$281
Sunovion Pharmaceuticals Inc.
$213
Indivior Inc.
$209
Merck Sharp & Dohme LLC
$180
Allergan, Inc.
$170
Medtronic, Inc.
$165
Merck Sharp & Dohme Corporation
$158
IDORSIA PHARMACEUTICALS US INC
$149
ShockWave Medical, Inc
$137
Novartis Pharmaceuticals Corporation
$136
Phathom Pharmaceuticals, Inc.
$135
Inari Medical, Inc.
$132
Stryker Corporation
$130
Braeburn Inc.
$125
Biohaven Pharmaceuticals, Inc.
$125
Ardelyx, Inc.
$115
Intuity Medical Inc
$111
Otsuka America Pharmaceutical, Inc.
$100
Azurity Pharmaceuticals, Inc.
$77
Akorn, Inc.
$76
Bayer Healthcare Pharmaceuticals Inc.
$66
SANOFI-AVENTIS U.S. LLC
$64
Astellas Pharma US Inc
$48
Biogen, Inc.
$40
Scilex Pharmaceuticals Inc.
$39
Biohaven Pharmaceutical Holding Company Ltd.
$32
IRONWOOD PHARMACEUTICALS, INC
$30
Horizon Pharma plc
$28
Kowa Pharmaceuticals America, Inc.
$28
Horizon Therapeutics plc
$25
Hikma Pharmaceuticals USA
$15
Eyevance Pharmaceuticals LLC
$15
Lundbeck LLC
$15
ACADIA Pharmaceuticals Inc
$14
SUN PHARMACEUTICAL INDUSTRIES INC.
$14
Sun Pharmaceutical Industries Inc.
$13
Regeneron Healthcare Solutions, Inc.
$13
Ultragenyx Pharmaceutical Inc.
$13
iRhythm Technologies, Inc.
$13
Alkermes, Inc.
$12
Mannkind Corporation
$11
Top 3 companies account for 42.8% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AFREZZA · AIRSUPRA · APRISO · APTIOM · AREXVY · AVYCAZ · Aimovig · BASAGLAR · BREO · BREZTRI · BRIXADI · BYDUREON · BYSTOLIC · CHANTIX · COMIRNATY · CREON · CardioInsight · Cologuard Collection Kit · DIFICID · DUEXIS · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · EZALLOR SPRINKLE · FARXIGA · FLOWTRIEVER CATHETER · HAWKONE · HORIZANT · Horizant · IBSRELA · Impella · JANUVIA · JARDIANCE · KAPSPARGO · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · LOKELMA · LYBALVI · Linzess · MOUNJARO · Mitigare · NUPLAZID · NURTEC ODT · Otezla · Ozempic · PENNSAID · PRALUENT · Pogo Automatic Blood Glucose Monitoring System · Prolia · QUVIVIQ · RELTONE 200 MG · REXULTI · RYBELSUS · Repatha · Reveal LINQ · Rybelsus · S · SHINGRIX · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SOLIQUA · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SYMBICORT · Saxenda · TEFLARO · TOUJEO · TRELEGY ELLIPTA · TREVO · TRIJARDY XR · TRULANCE · TRULICITY · Tobradex ST · Trulance · UBRELVY · VERQUVO · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · ZIO Patch · ZORYVE · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zioptan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for internal medicine in NJ.
Geographic Context
Internal medicine physicians within 10 mi
11,053
Per 100K population
1555.7
County median income
$90,032
Nearest hospital
CAREPOINT HEALTH-HOBOKEN UNIVERSITY MEDICAL CENTER
1.5 mi
1.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Amin is a clinical cardiology specialist, with above-average Medicare volume (top 4% in NJ), with low-engagement industry engagement in the top 2% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Amin experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Amin performed 1,133 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Amin receive payments from pharmaceutical companies?
Yes. Dr. Amin received a total of $31,374 from 60 companies across 717 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amin's costs compare to other internal medicine physicians in Union City?
Dr. Amin's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Union City
Browse internal medicine physicians in Union City ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
Synergy Pharmaceuticals Inc Payments to Doctors
See all physicians who received payments from Synergy Pharmaceuticals Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology